(Q44691485)

5 December 2017

title

Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experience (English)

1 reference

5 December 2017

Ping Tang

1

1 reference

5 December 2017

Leon Sun

2

1 reference

5 December 2017

Matthew A Uhlman

3

1 reference

5 December 2017

Thomas J Polascik

4

1 reference

5 December 2017

Stephen J Freedland

5

1 reference

5 December 2017

Judd W Moul

6

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

5 December 2017

1 reference

5 December 2017

volume

116

1 reference

5 December 2017

issue

20

1 reference

5 December 2017

page(s)

4711-4717

1 reference

5 December 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Screening for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Prostate-specific antigen levels as a predictor of lethal prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

The role of increasing detection in the rising incidence of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

A test of knowledge about prostate cancer screening. Online pilot evaluation among Southern California Physicians

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Management of localized prostate cancer in men over 65 years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Prostate specific antigen testing among the elderly--when to stop?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25447

7 January 2021

Identifiers

DOI

10.1002/CNCR.25447

1 reference

5 December 2017

1 reference